| Term 
 | Definition 
 
        | Substances that help in "self remedy" |  | 
        |  | 
        
        | Term 
 
        | What two drugs are considered autocoids? |  | Definition 
 
        | 1. Histamine 2. Antihistamines
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | By the decarboxylation of L-histidine |  | 
        |  | 
        
        | Term 
 
        | (T/F) This substance is exclusive to mammals |  | Definition 
 
        | False, it is also found in plants, venoms and stinging secretions |  | 
        |  | 
        
        | Term 
 
        | Where is histamine found in the body? |  | Definition 
 
        | Found in most tissues, sequestered and bound in granuls |  | 
        |  | 
        
        | Term 
 
        | What two cell types is histamine especially found in? |  | Definition 
 
        | 1. Mast cells 2. Basophils
 |  | 
        |  | 
        
        | Term 
 
        | (T/F) Histamine content of tissues proportional to the tissues mast cell content |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Where are mast cells found? |  | Definition 
 
        | At the sites of potential injury (nose, mouth, feet, lungs, GI mucosa) |  | 
        |  | 
        
        | Term 
 
        | (T/F) Histamine is also found in other cell types in the stomach |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What cell types contain histamine in the stomach, and what is the function of these cells/their histamine? |  | Definition 
 
        | - Found in enterochromaffin-like cells - Activate parietal cells to release HCl
 |  | 
        |  | 
        
        | Term 
 
        | What is a non-mast cell source of histamine, and how does it function in this tissue? |  | Definition 
 
        | The brain is a non-mast cell tissue that contains histamine, and it functions as a neurotransmitter here |  | 
        |  | 
        
        | Term 
 
        | What is the primary cause for release of histmaine, how is release triggered? |  | Definition 
 
        | Immunological response - IgE antibody binds to Fcepsilon1 receptors on mast cells - Ag binding to IgE causes mast cell degranulation
 |  | 
        |  | 
        
        | Term 
 
        | What type of receptors are the cell surface receptors for histamine? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | How many types are there, and name them? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Where is H1 located, and how does it evoke the responses in this tissue? |  | Definition 
 
        | - Found in smooth muscle (most important), endothelium and brain - Binding of histamine causes PIP2 pathway activation (Stimulatory)
 |  | 
        |  | 
        
        | Term 
 
        | Where is H2 located, and how does it evoke the responses in this tissue? |  | Definition 
 
        | - Found in gastric mucosa, cardiac muscle, mast cells and brain - Increases cAMP upon ligand binding (stimulatory)
 |  | 
        |  | 
        
        | Term 
 
        | Where is H3 located, and how does it evoke the responses in this tissue? |  | Definition 
 
        | - Found presynaptically, in the myenteric plexus and other neurons, and in the brain - Decreases cAMP upon binding with ligand (inhibitory)
 |  | 
        |  | 
        
        | Term 
 
        | Where is H4 located, and how does it evoke the responses in this tissue? |  | Definition 
 
        | - Found in blood cells - Decreases cAMP in these cells
 |  | 
        |  | 
        
        | Term 
 
        | What roles does H4 play in blood cells? (2) |  | Definition 
 
        | 1. Modulates production of blood cells 2. May be involved in cytokine production
 |  | 
        |  | 
        
        | Term 
 
        | What are the effects of histamine binding to H1 on the nervous system? |  | Definition 
 
        | Respiratory neuron signalling is modified |  | 
        |  | 
        
        | Term 
 
        | Which histamine receptor is found in bronchial smooth muscle? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What does histamine binding H1 here cause? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | (T/F) Small histamine doses elicit major responses in sensitive individuals (ie asthma patients) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Name the 3 types of histamine antagonists, and give an example of each |  | Definition 
 
        | 1. Physiological antagonist - epinephrine 2. Release inhibitors - cromolyn
 3. Receptor antagonists - antihistamines
 |  | 
        |  | 
        
        | Term 
 
        | Name the two classes of H1 antagonists |  | Definition 
 
        | 1: 1st generation 2. 2nd generation
 |  | 
        |  | 
        
        | Term 
 
        | Are beclomethazone, chloropheniramine and some phenothiazines considered 1st or 2nd generation antagonists? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Are loratadine, desloratadine, cetrizine, levocetirizine, and fexofenadine considered 1st or 2nd generation antagonists? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | (T/F) Both classes of antagonists are equally sedative |  | Definition 
 
        | False, only 1st gen are strongly sedative |  | 
        |  | 
        
        | Term 
 
        | What accounts for the difference in sedation between the two antagonist classes? |  | Definition 
 
        | 2nd gen do not penetrate the CNS as much as 1st gen |  | 
        |  | 
        
        | Term 
 
        | (T/F) Following this trend, 1st gen antagonists are more effective than 2nd gen antagonists in periphery tissues as well |  | Definition 
 
        | False, they are equally as effective |  | 
        |  | 
        
        | Term 
 
        | What are H1 antagonists primarily used for? |  | Definition 
 
        | Control/treatment of allergic reactions |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A resp disease/set if disease involving inflammation of airways and increased resistance to airflow |  | 
        |  | 
        
        | Term 
 
        | How is asthama characterized, clinically? (4) |  | Definition 
 
        | - Shortness of breath - Tightness in chest
 - Coughing
 - Wheezing
 |  | 
        |  | 
        
        | Term 
 
        | What 3 factors contribute to the increased airway resistance experienced in asthma? |  | Definition 
 
        | 1. Contraction of bronchiolar smooth muscle 2. Mucosal edema
 3. Bronchiolar secretions
 |  | 
        |  | 
        
        | Term 
 
        | (T/F) All 3 of these pathways can be targeted for effective drug treatment of asthma |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Describe the FEV1 vs Time graph seen during diagnosis of asthma patients. |  | Definition 
 
        | See an early reaction, where FEV1 drops to at least 70%. Then there is a recovery of FEV1, before the late reaction occurs and reduces FEV1 again |  | 
        |  | 
        
        | Term 
 
        | Which two cell types mediate the early reaction of asthma? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is the function of mast cells in the early response? (3) |  | Definition 
 
        | - Releases vasoactive amines that vasodilate vessels - Releases inflammatory mediators that bronchoconstrict (PGD2, LTC4, PAF)
 - Releases chemotactic cytokines
 |  | 
        |  | 
        
        | Term 
 
        | What two cell types mediate the late phase reaction? |  | Definition 
 
        | 1. Eosinophil 2. Neutrophils
 |  | 
        |  | 
        
        | Term 
 
        | What do eosinophils release, and what does it cause? |  | Definition 
 
        | ECP and MBP -> increase vessel permeability |  | 
        |  | 
        
        | Term 
 
        | What do neutrophils release, and what does it cause? |  | Definition 
 
        | PAF and proteases -> Increase mucous secretions and increase smooth muscle contraction |  | 
        |  | 
        
        | Term 
 
        | Describe tissue responses to inhaled irritants, that do not rely on the nervous system? |  | Definition 
 
        | The irritant itself causes tissue response - directly causes degranulation and the resulting responses |  | 
        |  | 
        
        | Term 
 
        | Describe tissue responses to inhaled irritants, that rely on the nervous system? |  | Definition 
 
        | Inhaled irritant acts on a sensory receptor, which then has its signal relayed by the vagal afferent to the CNS. The CNS then sends a resonse via the vagal efferent, which then causes the inflammatory response |  | 
        |  | 
        
        | Term 
 
        | How are anti-asthma drugs often administered, and why? |  | Definition 
 
        | Inhalation; because this way the drug is delivered to the site of action with the lowest possible dose - systemic responses are avoided |  | 
        |  | 
        
        | Term 
 
        | What are acute anti asthma drugs used for? |  | Definition 
 
        | Termination of asthma attack |  | 
        |  | 
        
        | Term 
 
        | What are prophylactic anti asthma drugs used for? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Name the 7 classes of anti-asthmatic drugs |  | Definition 
 
        | 1. Cromolyn sodium 2. Sympathomimetics
 3. Steroids
 4. Anticholinergics
 5. Methylxanthines
 6. Leukotriene pathway inhibitors
 7. Anti IgE antibody
 |  | 
        |  | 
        
        | Term 
 
        | Describe the mechanism, administration, therapeutical use and response time of cromolyn sodium |  | Definition 
 
        | M: Decreases release of bronchoconstrictor chemicals A: Inhalation, powder or liquid
 T: Used prophylactially
 R: Days to a month - patient compliance
 |  | 
        |  | 
        
        | Term 
 
        | (T/F) cromolyn sodium is absorbed if taken orally |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Describe the mechanism, administration, and therapeutical use sympathomimetics |  | Definition 
 
        | M: Beta2 and alpha stimulation A: Injection or inhalation
 T: In an emergency
 |  | 
        |  | 
        
        | Term 
 
        | (T/F) Different sympathomimetics are used to achieve different action times |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is a SABA, a LABA, and a uLABA? How long does each last? |  | Definition 
 
        | 1. SABA: Short acting beta 2 agonist (3-4 hours) 2. LABA: Long acting beta2 agonist (12 hrs)
 3. uLABA: ultra long acting beta2 agonist (24 hours)
 |  | 
        |  | 
        
        | Term 
 
        | What are common side effects of sympathomimetics? |  | Definition 
 
        | Insomnia, anxiety, tremor |  | 
        |  | 
        
        | Term 
 
        | Describe the mechanism, administration, therapeutical use and response time of steroids |  | Definition 
 
        | M: Anti inflammatory -> decrease eicosanoid synthesis A: Inhaled
 T: Prophylactically
 R: Hours
 |  | 
        |  | 
        
        | Term 
 
        | How do steroids carry out their actions? |  | Definition 
 
        | Alteration of transcription |  | 
        |  | 
        
        | Term 
 
        | (T/F) Often times, steroids are used in conjunction with long acting bronchodilators |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Describe the structure of anticholinergics? |  | Definition 
 
        | Quaternary N analogs of atropine |  | 
        |  | 
        
        | Term 
 
        | Describe the mechanism, administration, therapeutical use of anticholinergics |  | Definition 
 
        | M: Block cholinergic bronchoconstriction A: Inhaled
 T: For acute reaciton
 |  | 
        |  | 
        
        | Term 
 
        | Why are anticholinergics inhaled? |  | Definition 
 
        | To reduce the systemic effects of blocking cholinergic receptors |  | 
        |  | 
        
        | Term 
 
        | Describe the mechanism and therapeutical use of methylxanthines |  | Definition 
 
        | M: Bronchodilation without involving ACh or adrenergic receptors; blockade of adenosine receptors; others possible T: Prophylactically - long term control
 |  | 
        |  | 
        
        | Term 
 
        | (T/F) Methyxanthines only act in a certain area of the body |  | Definition 
 
        | False, they act in a multitude of locations |  | 
        |  | 
        
        | Term 
 
        | Describe their actions in the airways |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Describe their actions at the heart |  | Definition 
 
        | Stimulates HR and force of contraction |  | 
        |  | 
        
        | Term 
 
        | Describe their actions in the CNS |  | Definition 
 
        | - Stimulation/increased alertness - Stimulation of resp centre
 |  | 
        |  | 
        
        | Term 
 
        | What infantile condition are methylxanthines used to treat? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What occurs with high doses of methylxanthines? |  | Definition 
 
        | Convulsions, with resistance to anticonvulstants -> can lead to death |  | 
        |  | 
        
        | Term 
 
        | Describe their actions in the GIT |  | Definition 
 
        | Induce acid/pepsin secretion |  | 
        |  | 
        
        | Term 
 
        | Describe the involvement of beta agonists, theophylline, and muscarinic antagonists in treatment of asthma |  | Definition 
 
        | - All are bronchodilators - Beta agonists: increase production of cAMP by CA stimulation
 - Theophylline: blocks adenosine interacitions with bronchiolar smooth muscle, and prevents metabolism of cAMO
 - Muscarinic antagonists: prevent ACh actions at muscarinic receptos
 |  | 
        |  | 
        
        | Term 
 
        | (T/F) Leukotriene inhibitors are used to treat asthma |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Why is this? How does it work? |  | Definition 
 
        | Preventing the production of leukotrienes decreases inflammatory responses; leukotrienes are potent vasoconstrictors, |  | 
        |  | 
        
        | Term 
 
        | How does zileuton act in leukotriene inhibition? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | How does montelukast/zafirlukast act in leukotriene inhibition? |  | Definition 
 
        | CysLT1 receptor antagonists (counteract LTC4/LTCD4/LTCE4 actions) |  | 
        |  | 
        
        | Term 
 
        | How are leukotriene pathway inhibitors taken? How an this be advantageous over inhaled anti-asthmatics? |  | Definition 
 
        | Orally; better for patients with poor compliance |  | 
        |  | 
        
        | Term 
 
        | (T/F) Omalizumab is an example of anti-IgE antibody |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Prevents binding of IgE to mast cells by binding the FceR1 epitope, which prevents action |  | 
        |  | 
        
        | Term 
 
        | (T/F) Anti-IgE Ab is used for mild asthma |  | Definition 
 
        | False, only for moderate to severe cases |  | 
        |  | 
        
        | Term 
 
        | (T/F) Severe anaphylactic reactions are a potential hazard with this type of anti-asthmatic |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Name the 3 different was that Omalizumab combats asthmatic responses |  | Definition 
 
        | 1. Decreases FceR1 expression 2. Decreases mediator release
 3. Decreases allergic inflammation and prevents exacerbation/reduces symptoms
 |  | 
        |  | 
        
        | Term 
 
        | Desribe the asthma management continuum for treatment |  | Definition 
 
        | 1. Diagnosis 2. Environmental control
 3. SABA on Demand (if controlled) or SABA/LABA/ICS (if uncontrolled)
 4. Inhaled corticosteroids
 5. Add LABA (if teen) or increase ICS (if child) to ICS
 6. LTRA addition
 7. Anti IgE
 8. Prednisone
 |  | 
        |  | 
        
        | Term 
 
        | Give 4 examples of future asthma targets |  | Definition 
 
        | 1. Cytokine 2. CAM antagonists
 3. Protease inhibitors
 4. Immunomodulators
 |  | 
        |  | 
        
        | Term 
 
        | What would the role of immunomodulators (cytokines) do, and how would this help? |  | Definition 
 
        | Shift from TH2 to TH1 - less antibody mediated response |  | 
        |  | 
        
        | Term 
 
        | How would cytokines be targeted? |  | Definition 
 
        | Abs that target IL -4,-5,-13 would be made |  | 
        |  |